Joyzyme Says Cheng Remains Suitable as Audit Committee Chair Despite Regulatory Reprimand

• Joyzyme Group reaffirmed Dr. Cheng Faat Ting Gary’s suitability as independent non-executive director and audit committee chairman following an AFRC disciplinary review.
• The board acknowledged serious independence breaches and audit-evidence failures involving a single third-party audit unrelated to the group.
• Sanctions comprised a public reprimand and monetary penalty, with no restrictions on Cheng’s audit practice.
• The board sees no impact on financial position or operations and no need to appoint an additional independent director.
• The audit committee will increase its focus on external auditor independence and quality control.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Joyzyme Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261106-12404368), on November 06, 2026, and is solely responsible for the information contained therein.